These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10220543)

  • 1. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.
    Haq IU; Ramsay LE; Yeo WW; Jackson PR; Wallis EJ
    Heart; 1999 Jan; 81(1):40-6. PubMed ID: 10220543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.
    Empana JP; Ducimetière P; Arveiler D; Ferrières J; Evans A; Ruidavets JB; Haas B; Yarnell J; Bingham A; Amouyel P; Dallongeville J;
    Eur Heart J; 2003 Nov; 24(21):1903-11. PubMed ID: 14585248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy.
    Broedl UC; Geiss HC; Parhofer KG
    J Gen Intern Med; 2003 Mar; 18(3):190-5. PubMed ID: 12648250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.
    Vrentzos GE; Papadakis JA; Ganotakis ES; Paraskevas KI; Gazi IF; Tzanakis N; Nair DR; Mikhailidis DP
    Int J Clin Pract; 2007 Oct; 61(10):1643-53. PubMed ID: 17877651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary heart disease risk assessment in diabetes mellitus--a comparison of PROCAM and Framingham risk assessment functions.
    Game FL; Jones AF
    Diabet Med; 2001 May; 18(5):355-9. PubMed ID: 11472444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
    Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
    JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.
    Assmann G; Schulte H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1713-24. PubMed ID: 3202078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?
    Wang Z; Hoy WE
    Med J Aust; 2005 Jan; 182(2):66-9. PubMed ID: 15651963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study.
    Cooper JA; Miller GJ; Humphries SE
    Atherosclerosis; 2005 Jul; 181(1):93-100. PubMed ID: 15939059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods.
    Haq IU; Ramsay LE; Jackson PR; Wallis EJ
    QJM; 1999 Jul; 92(7):379-85. PubMed ID: 10627887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
    Ferrario M; Chiodini P; Chambless LE; Cesana G; Vanuzzo D; Panico S; Sega R; Pilotto L; Palmieri L; Giampaoli S;
    Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil.
    Barros ZM; de Alencar Ximenes RA; Miranda-Filho DB; de Albuquerque Mde F; Melo HR; Carvalho EH; Gelenske T; Diniz G; Bandeira F
    Metab Syndr Relat Disord; 2010 Dec; 8(6):489-97. PubMed ID: 20973693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Framingham prediction rule is not valid in a European population of treated hypertensive patients.
    Bastuji-Garin S; Deverly A; Moyse D; Castaigne A; Mancia G; de Leeuw PW; Ruilope LM; Rosenthal T; Chatellier G;
    J Hypertens; 2002 Oct; 20(10):1973-80. PubMed ID: 12359975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts.
    Hense HW; Schulte H; Löwel H; Assmann G; Keil U
    Eur Heart J; 2003 May; 24(10):937-45. PubMed ID: 12714025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.
    D'Agostino RB; Grundy S; Sullivan LM; Wilson P;
    JAMA; 2001 Jul; 286(2):180-7. PubMed ID: 11448281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM).
    Knobel H; Jericó C; Montero M; Sorli ML; Velat M; Guelar A; Saballs P; Pedro-Botet J
    AIDS Patient Care STDS; 2007 Jul; 21(7):452-7. PubMed ID: 17651026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac risk in men with angiographically normal coronary arteries or minimal coronary arteriosclerosis].
    Schulz H; Sinn R; Wolf R
    Z Kardiol; 2003 Mar; 92(3):245-53. PubMed ID: 12658472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population.
    de Visser CL; Bilo HJ; Thomsen TF; Groenier KH; Meyboom-de Jong B
    J Intern Med; 2003 May; 253(5):553-62. PubMed ID: 12702033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.